Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
0.6830
-0.0512 (-6.97%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Celularity Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 6.18 | 0.74 | 0.23 | 13.97 | 37.24 |
Cash & Short-Term Investments | 6.18 | 0.74 | 0.23 | 13.97 | 37.24 |
Cash Growth | 736.72% | 225.11% | -98.38% | -62.50% | -31.43% |
Accounts Receivable | 4.65 | 13.56 | 10.05 | 4.45 | 2.75 |
Other Receivables | - | - | 2.07 | 2.51 | 2.49 |
Total Trade Receivables | 4.65 | 13.56 | 12.12 | 6.97 | 5.23 |
Inventory | 0.57 | 5.41 | 5.75 | 5.31 | 9.55 |
Other Current Assets | 0.92 | 0.86 | 1.7 | 7.26 | 7.08 |
Total Current Assets | 12.32 | 20.56 | 19.79 | 33.5 | 59.1 |
Net Property, Plant & Equipment | 66.52 | 72.43 | 78.82 | 88.72 | 90.63 |
Other Intangible Assets | 7.76 | 9.25 | 11 | 120.99 | 123.19 |
Goodwill | 7.35 | 7.35 | 7.35 | 119.69 | 123.3 |
Other Long-Term Assets | 13.39 | 23.1 | 26.93 | 38.16 | 17.91 |
Total Assets | 107.33 | 132.68 | 143.89 | 401.07 | 414.13 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 26.42 | 23.3 | 14.14 | 5.81 | 9.32 |
Accrued Expenses | 32.57 | 20.49 | 7.58 | 9.07 | 11.66 |
Short-Term Debt | 14 | 6.36 | 39.24 | 37.6 | - |
Current Portion of Long-Term Debt | - | - | - | - | 3.05 |
Unearned Revenue | 5.26 | 3.53 | 2.83 | 2.27 | 2.2 |
Other Current Liabilities | 2.51 | - | 3.5 | 7.33 | - |
Total Current Liabilities | 80.76 | 53.68 | 67.3 | 62.09 | 26.23 |
Long-Term Debt | - | 35.93 | - | - | - |
Long-Term Leases | 26.9 | 26.55 | 26.18 | 27.99 | - |
Other Long-Term Liabilities | 37.73 | 7.69 | 9.45 | 112.09 | 288.49 |
Total Long-Term Liabilities | 64.63 | 70.17 | 35.63 | 140.08 | 288.49 |
Total Liabilities | 145.39 | 123.85 | 102.93 | 202.17 | 314.71 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0.02 | 0.02 | 0.01 |
Additional Paid-in Capital | 953.42 | 908.52 | 882.73 | 844.37 | 763.09 |
Accumulated Other Comprehensive Income | - | -0.01 | - | 0.01 | - |
Retained Earnings | -991.48 | -899.68 | -841.79 | -645.5 | -663.68 |
Total Common Shareholders' Equity | -38.06 | 8.84 | 40.96 | 198.9 | 99.42 |
Shareholders' Equity | -38.06 | 8.84 | 40.96 | 198.9 | 99.42 |
Total Liabilities & Equity | 107.33 | 132.68 | 143.89 | 401.07 | 414.13 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 40.9 | 68.84 | 65.42 | 65.59 | 3.05 |
Net Cash (Debt) | -34.73 | -68.1 | -65.19 | -51.62 | 34.19 |
Net Cash Growth | - | - | - | - | -33.36% |
Net Cash Per Share | -1.36 | -3.11 | -3.66 | -3.44 | 5.10 |
Book Value | -38.06 | 8.84 | 40.96 | 198.9 | 99.42 |
Book Value Per Share | -1.49 | 0.40 | 2.30 | 13.28 | 14.83 |
Tangible Book Value | -53.17 | -7.76 | 22.61 | -41.79 | -147.07 |
Tangible Book Value Per Share | -2.08 | -0.35 | 1.27 | -2.79 | -21.93 |